F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 1,125 | 0 | 2,551 | 17,499 | 751 |
| Gross Profit | 1,125 | N/A | 2,551 | 17,499 | 751 |
| Operating Expenses | 14,831 | 16,181 | 13,739 | 13,176 | 10,352 |
| Operating Income | -13,706 | -16,181 | -11,188 | 4,323 | -9,601 |
| Interest Expense | 378 | 334 | 308 | 322 | 325 |
| Other Income | -4,323 | -2,479 | -591 | 178 | -865 |
| Pre-tax Income | -18,407 | -18,994 | -12,087 | 4,179 | -10,791 |
| Income Tax | N/A | N/A | N/A | -562 | N/A |
| Net Income Continuous | -18,407 | -18,994 | -12,087 | 4,741 | -10,791 |
| Net Income | $-18,407 | $-18,994 | $-12,087 | $4,741 | $-10,791 |
| EPS Basic Total Ops | -0.84 | -0.88 | -0.57 | 0.62 | -0.52 |
| EPS Basic Continuous Ops | -0.84 | -0.88 | -0.57 | 0.62 | -0.52 |
| EPS Diluted Total Ops | -0.84 | -0.88 | -0.57 | 0.62 | -0.52 |
| EPS Diluted Continuous Ops | -0.84 | -0.88 | -0.57 | 0.62 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.84 | -0.88 | -0.57 | 0.47 | -0.52 |
| EBITDA(a) | $-13,464 | $-15,983 | $-10,959 | $4,488 | $-9,329 |